• Home
  • >
  • Divis Laboratories Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/divis-laboratories-ltd.png Logo

Divis Laboratories Ltd Financial Statement

Divis Laboratories Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue1,9021,9531,810
Operating Expense1,3171,3941,239
Net Profit358342345
Net Profit Margin18.8217.5119.06
Earning Per Share13.512.8912.99
EBIDTA574545561
Effective Tax Rate20.6819.3221.54

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Divis Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual7,767.518,959.836,969.4
Operating Expenses Annual5,399.695,077.894,109.46
Operating Profit Annual2,712.483,995.812,922.5
Interest Annual0.670.80.87
Depreciation339.26308.33252.62
Net Profit Annual1,823.382,960.451,984.29
Tax Annual545.25723.05681.75

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Divis Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning1,214.762,030.3243.15
Cash Flow from Operations2,459.731,911.81,946.93
Cash Flow from Investing-2,707.62-2,194.9275.13
Cash Flow from Financing-797.17-532.44-34.89
Cash Flow at the End169.71,214.762,030.32

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Divis Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)34.9444.6141.95
PBIT Margin (%)30.5241.1338.28
PBT Margin (%)14.6620.3819.59
Net PROFIT Margin (%)23.7133.228.75
Return On Networth / Equity (%)14.8928.1623.9
Return On Networth /Employed(%)19.334.9631.97
Return On Assets (%)14.9428.2223.86
Total Debt / Equity(X)TBATBATBA
Asset Turnover Ratio (%)0.630.850.83

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Divis Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual4,722.64,325.053,703.87
Total Current Assets Annual9,311.748,351.56,174.71
Non Current Assets Annual5,127.035,023.214,599.36
Total Shareholders Funds Annual12,767.0911,728.189,294.61
Total Assets Annual14,438.7713,374.7110,774.07

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Divis Laboratories Ltd Earning Calls
Dec 2023
EPS beaten by -0.07 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Divis Laboratories Ltd has a market capitalization of 75,014.78 Cr. Value Research classifies it as a Large-Cap company.

Yes, Divis Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2023, Divis Laboratories Ltd recorded a total revenue of approximately 7,767 Cr marking a significant milestone in the company's financial performance.

Divis Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.1% annually, respectively..

Divis Laboratories Ltd's current PE ratio is 41.13.

Divis Laboratories Ltd's ROCE averaged 26.2% from the FY ending March 2021 to 2023, with a median of 28.7%. It peaked at 31.4% in March 2022, reflecting strong capital efficiency over the period..

Divis Laboratories Ltd's latest EBIT is Rs. 2,370 Cr, surpassing the average EBIT of Rs. 2,907.07 Cr over the 5 years..